Company Overview

PRIME exits® and American Healthcare Capital are proud to exclusively represent a dental implant manufacturer for sale. The Company is a founder-led, vertically integrated dental implant and digital dentistry platform founded in 2008. The business develops and manufactures dental implant systems, prosthetics, surgical kits, surgical tools, digital workflow solutions and intra-oral scanning products, serving more than 25 countries through a mix of distributors, subsidiaries and direct channels.

Manufacturing and Operations

Products are developed and manufactured outside of the United States. However, they are FDA-approved with strong IP protection, and are currently being sold in the U.S. The operating model is inventory-based, allowing for short delivery times, and is supported by a warehouse in Spain that facilitates international distribution.

Management is also evaluating the addition of supplemental manufacturing capabilities in Germany and potentially in the United States, leveraging government-supported initiatives that promote domestic, business-friendly manufacturing.

Sales Distribution by Country

The top disclosed revenue territories are China (33%), Israel (20%), Hungary (11%), Spain (7%) and Puerto Rico (4%), with the balance generated across other international markets including the United States.

Financial Snapshot

The Company generated $9.3 million of revenue and $2.6 million of EBITDA in 2024. Preliminary 2025 results indicate revenue of $8.4 million and EBITDA of $1.3 million, based on the year-end trial balance. Looking ahead, management projects a recovery in 2026, with revenue expected to reach $10.0 million and EBITDA of $2.0 million.

Investment Highlights

• Vertically integrated manufacturing model

• Clinician-led R&D 

• Patent-protected drill-less implant concept

• Integrated digital workflow positioning

• International distributor footprint

• Clear runway for U.S. and European expansion

Transaction Overview

The shareholders are open to a majority sale, major recapitalization, minority growth investment or structured strategic partnership. Management is open to retaining ownership, rolling equity and remaining involved post-close. 

Asking Price

The asking price for this opportunity is $20.0 million. The asking price excludes cash, working capital, inventory, accounts receivables, and any real properties.